Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule, 90-count — NDC 24385-125-96 (Billing 24385-0125-96)
by Amerisourcebergen Drug Corporation · 90 CAPSULE in 1 BOTTLE, PLASTIC
This is a package of 90 capsules of Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule from Amerisourcebergen Drug Corporation, marketed since Jul 2010 and currently FDA-listed.
NDC 24385-0125-96
🏷️ FDA NDC (as labeled)
24385-125-96
billing pads the product segment with a zero
This package
Contains90-count
Pack sizes3 compare ↓
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
24385-125-96
Product NDC
24385-125
11-digit billing NDC
24385012596
UNII
8F049NKY49
Application #
M007
SPL Set ID
4911fb44-e070-46c1-8f90-b78ceb10e51e
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2010-07-13
Route
ORAL
Dosage form
CAPSULE
Substance
CALCIUM POLYCARBOPHIL
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
46300020100310
GPI class
GNP Fiber-Caps
GCN Seq No
003065
GCN
08342
HICL code
001346
Ingredient (HICL)
Calcium Polycarbophil
HIC1 code
D
Therapeutic class — broad (HIC1)
Biliary System/Gastro-Intestinal System
HIC2 code
D6
Therapeutic class — intermediate (HIC2)
Drugs Acting Principally On The Colon
HIC3 code
D6S
Therapeutic class — specific (HIC3)
Laxatives And Cathartics
AHFS code
56:12.00.00
AHFS class
Cathartics And Laxatives
FDB label name
FIBER TABS
FDB brand name
Fiber Tabs
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 003065
- GCN: 08342
- GPI-14 (Medi-Span): 46300020100310
- HICL (First Databank): 001346
- AHFS class code: 56:12.00.00
Why two NDCs?
The FDA registers this code as 24385-125-96 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24385-0125-96. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Label name FIBER TABS Ingredient Calcium Polycarbophil
🧪 What is this product?
This is an oral capsule containing calcium polycarbophil, an over-the-counter laxative product sold under FDA's established monograph rules for this category. Calcium polycarbophil is typically used to relieve occasional constipation by absorbing water in the intestines and forming a larger stool mass that encourages bowel movement. The product is labeled as stimulant-free, meaning it works through a different mechanism than stimulant laxatives.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Calcium Polycarbophil — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about Calcium Polycarbophil?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Marketing end | Status |
|---|---|---|---|---|---|---|
| 24385-0125-27 24385-125-27 | 90 CAPSULE in 1 BOTTLE, PLASTIC | — | — | 2010-07-13 | — | Active |
| 24385-0125-76 24385-125-76 Main listing | 90 CAPSULE in 1 BOTTLE | $0.0591 / ea | $5.32 | 2024-06-20 | — | Active |
| 24385-0125-96 You're viewing this | 90 CAPSULE in 1 BOTTLE, PLASTIC | — | — | 2010-07-13 | — | Active |
This pack shows little to no recent Medicaid volume — the 90 capsules pack carries most fills. See all packs ↓
Pack size FAQ
What quantity is in this package?
This is a 90-count package — 90 capsule in 1 bottle, plastic.
How does this package differ from NDC 24385-0125-27?
Both are Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule — the drug itself is identical. This page's package is the 90-count one, while NDC 24385-0125-27 is the 90 capsules package.
What NDC number is used to bill for this package of Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Fiber Lax 625 mg 00536-4306-05 | Rugby | 500 tablets | $0.059 | — | Availability likely | — |
| Fiber Tabs 625 mg 00904-2500-91 | Major | 90 tablets | $0.059 | — | Availability likely | — |
| Calcium Polycarbophil 625 mg 70000-0067-01 | LEADER/ | 250 tablets | $0.059 | — | Availability likely | — |
| Foster and Thrive Fiber Laxative 147 625 mg 70677-1083-01 | Strategic | 90 tablets | $0.059 | — | Availability likely | — |
| Fiber caplets 147 625 mg 83324-0131-90 | Chain | 90 tablets | $0.059 | — | Availability likely | — |
| Walgreen Fiber Lax 625 mg 00363-0120-14 | WALGREENS | 140 tablets | — | — | FDA listed | — |
| up and up fiber therapy 625 mg 11673-0620-90 | Target | 140 tablets | — | — | FDA listed | — |
| Rite Aid Fiber Caplets 625 mg 11822-2025-00 | RITE | 250 tablets | — | — | FDA listed | — |
| Fiber Caplets 625 mg 21130-0021-40 | SAFEWAY | 140 tablets | — | — | FDA listed | — |
| Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free 625 mgthis 24385-0125-96 | Amerisourcebergen | 90 capsules | — | — | FDA listed | — |
| Fiber Caplets 625 mg 30142-0132-14 | THE | 140 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 36800-0465-27 | Topco | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 41163-0147-94 | UNITED | 140 tablets | — | — | FDA listed | — |
| Publix 625 mg 41415-0021-90 | PUBLIX | 90 tablets | — | — | FDA listed | — |
| Fiber Therapy 625 mg 49035-0147-94 | Wal-Mart | 140 tablets | — | — | FDA listed | — |
| Goodsense Fiber laxative 147 625 mg 50804-0147-94 | GoodSense | 140 tablets | — | — | FDA listed | — |
| Fiber Caps 625 mg 53041-0147-27 | Guardian | 90 tablets | — | — | FDA listed | — |
| Fiber laxative 625 mg 53943-0147-27 | Discount | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 54257-0379-07 | Magno-Humphries, | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 54257-0479-07 | Magno-Humphries, | 90 tablets | — | — | FDA listed | — |
| Fiber Lax 625 mg 55289-0949-30 | PD-Rx | 30 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 57896-0459-09 | Geri-Care | 90 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 58624-5003-01 | SHANDONG | 90 tablets | — | — | FDA listed | — |
| Quality Choice 625 mg 63868-0530-90 | QUALITY | 90 tablets | — | — | FDA listed | — |
| Best Choice 625 mg 63941-0023-90 | BEST | 90 tablets | — | — | FDA listed | — |
| Premier Value 625 mg 68016-0220-25 | PHARMACY | 250 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 69842-0846-02 | CVS | 250 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 70369-0006-08 | CITRAGEN | 120 tablets | — | — | FDA listed | — |
| Amazon Fiber Caplets 625 mg 72288-0201-40 | AMAZON.COM | 140 tablets | — | — | FDA listed | — |
| Fiber Laxative Caplets 625 mg 77333-0120-50 | Gendose | 50 tablets | — | — | FDA listed | — |
| Meijer Fiber Caplets 625 mg 79481-1205-00 | MEIJER | 250 tablets | — | — | FDA listed | — |
| Fibercon 625 mg 80070-0500-14 | Foundation | 140 tablets | — | — | FDA listed | — |
| Quality Choice Fiber Caplets 625 mg 83324-0276-14 | QUALITY | 140 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2010
On the market since
Jul 2010
📍
2026
Currently FDA-listed
16 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Sep 3, 2026
What it looks like
Color
white
Shapecapsule
ImprintG147
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII H0G9379FGK
Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
-
UNII T9D99G2B1R
Caramel is a brown coloring substance made by heating sugar. It's added to medicines to give them color and sometimes a slight sweet taste without affecting how the drug works.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 2S7830E561
Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
-
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 3WJQ0SDW1A
Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
9 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statescalcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerAmerisourcebergen Drug Corporation
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code24385
First marketedJul 2010
Product typeHuman Otc Drug
Portfolio37 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses relieves: occasional constipation this product generally produces bowel movement in 12 to 72 hours
⏱️ Dosage and Administration ▾
Directions take this product (child or adult dose) with a full glass of water (8oz.) or other fluid. Taking this product without enough liquid may cause choking. See choking warning. dosage will vary according to diet, exercise, previous laxative use or severity of constipation continued use for 1 to 3 days is normally required to provide full benefit adults and children 12 years & over 2 caplets, 1 to 4 times a day children under 12 years ask a doctor
⚠️ Warnings ▾
Warnings Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
Ask a doctor before use if you have abdominal pain, nausea or vomiting difficulty in swallowing a sudden change in bowel habits that persists over a period of 2 weeks Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.
When using this product do not use for more than 7 days unless directed by a doctor do not take more than 8 caplets in a 24 hour period unless directed by a doctor Stop use and ask a doctor if you experience chest pain, abdominal pain, nausea, vomiting, difficulty in breathing or swallowing you fail to have a bowel movement after use rectal bleeding occurs These could be signs of serious condition. Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.
📦 Storage and Handling ▾
Other information each caplet contains: calcium 135 mg store at room temperature protect contents from moisture
🧪 Active Ingredient ▾
Active ingredient (in each caplet) Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil
🧪 Inactive Ingredients ▾
Inactive ingredients calcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.
🎯 Purpose ▾
Purpose Bulk-forming laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 483 Rx · 33,373 units · $4,862 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 43%
Female · 57%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Amerisourcebergen Drug Corporation. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 90 capsules (24385-0125-27), 90 capsules (24385-0125-76). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Amerisourcebergen Drug Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.